本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

25.57
-0.9200-3.47%
盘前:25.680.1100+0.43%04:01 EDT
成交量:312.20万
成交额:7,906.48万
市值:40.85亿
市盈率:-62.17
高:26.49
开:26.31
低:24.76
收:26.49
52周最高:30.74
52周最低:12.00
股本:1.60亿
流通股本:1.25亿
量比:1.52
换手率:2.50%
股息:- -
股息率:- -
每股收益(TTM):-0.4113
每股收益(LYR):-0.3922
净资产收益率:-38.76%
总资产收益率:-4.12%
市净率:28.58
市盈率(LYR):-65.20

数据加载中...

2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities